nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—HTR2A—pancreatitis	0.781	1	CbGaD
Cyclobenzaprine—Accommodation disorder—Propantheline—pancreatitis	0.0122	0.0593	CcSEcCtD
Cyclobenzaprine—Mydriasis—Propantheline—pancreatitis	0.00877	0.0427	CcSEcCtD
Cyclobenzaprine—Ileus paralytic—Hyoscyamine—pancreatitis	0.00828	0.0403	CcSEcCtD
Cyclobenzaprine—Excitement—Hyoscyamine—pancreatitis	0.0073	0.0355	CcSEcCtD
Cyclobenzaprine—Accommodation disorder—Hyoscyamine—pancreatitis	0.00623	0.0303	CcSEcCtD
Cyclobenzaprine—Thirst—Propantheline—pancreatitis	0.00533	0.026	CcSEcCtD
Cyclobenzaprine—Paranoia—Hyoscyamine—pancreatitis	0.00525	0.0256	CcSEcCtD
Cyclobenzaprine—Mydriasis—Hyoscyamine—pancreatitis	0.00449	0.0218	CcSEcCtD
Cyclobenzaprine—Ageusia—Hyoscyamine—pancreatitis	0.00442	0.0215	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Propantheline—pancreatitis	0.00404	0.0197	CcSEcCtD
Cyclobenzaprine—Drowsiness—Propantheline—pancreatitis	0.00391	0.019	CcSEcCtD
Cyclobenzaprine—Dysarthria—Hyoscyamine—pancreatitis	0.00378	0.0184	CcSEcCtD
Cyclobenzaprine—Muscle twitching—Hyoscyamine—pancreatitis	0.00364	0.0177	CcSEcCtD
Cyclobenzaprine—Hypertonia—Hyoscyamine—pancreatitis	0.00314	0.0153	CcSEcCtD
Cyclobenzaprine—Tension—Propantheline—pancreatitis	0.003	0.0146	CcSEcCtD
Cyclobenzaprine—Nervousness—Propantheline—pancreatitis	0.00297	0.0145	CcSEcCtD
Cyclobenzaprine—Disorientation—Hyoscyamine—pancreatitis	0.0029	0.0141	CcSEcCtD
Cyclobenzaprine—Vision blurred—Propantheline—pancreatitis	0.00288	0.014	CcSEcCtD
Cyclobenzaprine—Thirst—Hyoscyamine—pancreatitis	0.00273	0.0133	CcSEcCtD
Cyclobenzaprine—Palpitations—Propantheline—pancreatitis	0.0027	0.0132	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Hyoscyamine—pancreatitis	0.0026	0.0126	CcSEcCtD
Cyclobenzaprine—Dry mouth—Propantheline—pancreatitis	0.00254	0.0124	CcSEcCtD
Cyclobenzaprine—Psychotic disorder—Hyoscyamine—pancreatitis	0.00254	0.0124	CcSEcCtD
Cyclobenzaprine—Confusional state—Propantheline—pancreatitis	0.00252	0.0122	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Propantheline—pancreatitis	0.00249	0.0121	CcSEcCtD
Cyclobenzaprine—Irritability—Hyoscyamine—pancreatitis	0.00248	0.0121	CcSEcCtD
Cyclobenzaprine—Urinary retention—Hyoscyamine—pancreatitis	0.00247	0.012	CcSEcCtD
Cyclobenzaprine—Ataxia—Hyoscyamine—pancreatitis	0.00244	0.0119	CcSEcCtD
Cyclobenzaprine—Tachycardia—Propantheline—pancreatitis	0.00243	0.0119	CcSEcCtD
Cyclobenzaprine—Insomnia—Propantheline—pancreatitis	0.00226	0.011	CcSEcCtD
Cyclobenzaprine—Somnolence—Propantheline—pancreatitis	0.00222	0.0108	CcSEcCtD
Cyclobenzaprine—Constipation—Propantheline—pancreatitis	0.00213	0.0104	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Hyoscyamine—pancreatitis	0.00207	0.0101	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Propantheline—pancreatitis	0.00206	0.01	CcSEcCtD
Cyclobenzaprine—Drowsiness—Hyoscyamine—pancreatitis	0.002	0.00975	CcSEcCtD
Cyclobenzaprine—Urticaria—Propantheline—pancreatitis	0.00198	0.00965	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Hyoscyamine—pancreatitis	0.00197	0.00961	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Hyoscyamine—pancreatitis	0.00196	0.00956	CcSEcCtD
Cyclobenzaprine—Sweating—Hyoscyamine—pancreatitis	0.00192	0.00935	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Propantheline—pancreatitis	0.00184	0.00895	CcSEcCtD
Cyclobenzaprine—Asthenia—Propantheline—pancreatitis	0.00179	0.00871	CcSEcCtD
Cyclobenzaprine—Hallucination—Hyoscyamine—pancreatitis	0.00179	0.00871	CcSEcCtD
Cyclobenzaprine—Dizziness—Propantheline—pancreatitis	0.00165	0.00803	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Hyoscyamine—pancreatitis	0.00161	0.00782	CcSEcCtD
Cyclobenzaprine—Vomiting—Propantheline—pancreatitis	0.00159	0.00772	CcSEcCtD
Cyclobenzaprine—Rash—Propantheline—pancreatitis	0.00157	0.00766	CcSEcCtD
Cyclobenzaprine—Dermatitis—Propantheline—pancreatitis	0.00157	0.00765	CcSEcCtD
Cyclobenzaprine—Headache—Propantheline—pancreatitis	0.00156	0.00761	CcSEcCtD
Cyclobenzaprine—Tension—Hyoscyamine—pancreatitis	0.00154	0.00748	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Hyoscyamine—pancreatitis	0.00153	0.00746	CcSEcCtD
Cyclobenzaprine—Nervousness—Hyoscyamine—pancreatitis	0.00152	0.0074	CcSEcCtD
Cyclobenzaprine—Nausea—Propantheline—pancreatitis	0.00148	0.00721	CcSEcCtD
Cyclobenzaprine—Vision blurred—Hyoscyamine—pancreatitis	0.00147	0.00718	CcSEcCtD
Cyclobenzaprine—Agitation—Hyoscyamine—pancreatitis	0.00144	0.007	CcSEcCtD
Cyclobenzaprine—Angioedema—Hyoscyamine—pancreatitis	0.00143	0.00696	CcSEcCtD
Cyclobenzaprine—Vertigo—Hyoscyamine—pancreatitis	0.00141	0.00684	CcSEcCtD
Cyclobenzaprine—Syncope—Hyoscyamine—pancreatitis	0.0014	0.00683	CcSEcCtD
Cyclobenzaprine—Palpitations—Hyoscyamine—pancreatitis	0.00138	0.00673	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Hyoscyamine—pancreatitis	0.00138	0.0067	CcSEcCtD
Cyclobenzaprine—Convulsion—Hyoscyamine—pancreatitis	0.00136	0.0066	CcSEcCtD
Cyclobenzaprine—Chest pain—Hyoscyamine—pancreatitis	0.00133	0.00649	CcSEcCtD
Cyclobenzaprine—Anxiety—Hyoscyamine—pancreatitis	0.00133	0.00646	CcSEcCtD
Cyclobenzaprine—Dry mouth—Hyoscyamine—pancreatitis	0.0013	0.00634	CcSEcCtD
Cyclobenzaprine—Confusional state—Hyoscyamine—pancreatitis	0.00129	0.00627	CcSEcCtD
Cyclobenzaprine—Oedema—Hyoscyamine—pancreatitis	0.00128	0.00622	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Hyoscyamine—pancreatitis	0.00128	0.00622	CcSEcCtD
Cyclobenzaprine—Shock—Hyoscyamine—pancreatitis	0.00126	0.00612	CcSEcCtD
Cyclobenzaprine—Tachycardia—Hyoscyamine—pancreatitis	0.00125	0.00607	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Hyoscyamine—pancreatitis	0.00123	0.00601	CcSEcCtD
Cyclobenzaprine—Hypotension—Hyoscyamine—pancreatitis	0.00119	0.00581	CcSEcCtD
Cyclobenzaprine—Insomnia—Hyoscyamine—pancreatitis	0.00115	0.00562	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Hyoscyamine—pancreatitis	0.00114	0.00554	CcSEcCtD
Cyclobenzaprine—Somnolence—Hyoscyamine—pancreatitis	0.00114	0.00553	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Hyoscyamine—pancreatitis	0.00112	0.00547	CcSEcCtD
Cyclobenzaprine—Fatigue—Hyoscyamine—pancreatitis	0.0011	0.00536	CcSEcCtD
Cyclobenzaprine—Constipation—Hyoscyamine—pancreatitis	0.00109	0.00532	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Hyoscyamine—pancreatitis	0.00105	0.00512	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.00104	0.00508	CcSEcCtD
Cyclobenzaprine—Urticaria—Hyoscyamine—pancreatitis	0.00101	0.00494	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Hyoscyamine—pancreatitis	0.00101	0.00491	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Hyoscyamine—pancreatitis	0.000941	0.00458	CcSEcCtD
Cyclobenzaprine—Asthenia—Hyoscyamine—pancreatitis	0.000916	0.00446	CcSEcCtD
Cyclobenzaprine—Pruritus—Hyoscyamine—pancreatitis	0.000903	0.0044	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Hyoscyamine—pancreatitis	0.000874	0.00425	CcSEcCtD
Cyclobenzaprine—Dizziness—Hyoscyamine—pancreatitis	0.000844	0.00411	CcSEcCtD
Cyclobenzaprine—Vomiting—Hyoscyamine—pancreatitis	0.000812	0.00395	CcSEcCtD
Cyclobenzaprine—Rash—Hyoscyamine—pancreatitis	0.000805	0.00392	CcSEcCtD
Cyclobenzaprine—Dermatitis—Hyoscyamine—pancreatitis	0.000804	0.00392	CcSEcCtD
Cyclobenzaprine—Headache—Hyoscyamine—pancreatitis	0.0008	0.00389	CcSEcCtD
Cyclobenzaprine—Nausea—Hyoscyamine—pancreatitis	0.000759	0.00369	CcSEcCtD
Cyclobenzaprine—Cyproheptadine—HTR2A—pancreatitis	0.000338	0.154	CrCbGaD
Cyclobenzaprine—Chlorprothixene—HTR2A—pancreatitis	0.000233	0.106	CrCbGaD
Cyclobenzaprine—Nortriptyline—HTR2A—pancreatitis	0.000229	0.104	CrCbGaD
Cyclobenzaprine—Trimipramine—HTR2A—pancreatitis	0.000216	0.0982	CrCbGaD
Cyclobenzaprine—Promethazine—HTR2A—pancreatitis	0.000208	0.0945	CrCbGaD
Cyclobenzaprine—Doxepin—HTR2A—pancreatitis	0.000206	0.0936	CrCbGaD
Cyclobenzaprine—Promazine—HTR2A—pancreatitis	0.000183	0.0832	CrCbGaD
Cyclobenzaprine—CYP1A2—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.000178	0.0158	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.00017	0.0151	CbGpPWpGaD
Cyclobenzaprine—Imipramine—HTR2A—pancreatitis	0.00016	0.0728	CrCbGaD
Cyclobenzaprine—Amitriptyline—HTR2A—pancreatitis	0.000159	0.0723	CrCbGaD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.000158	0.0141	CbGpPWpGaD
Cyclobenzaprine—Nortriptyline—ALB—pancreatitis	0.000157	0.0713	CrCbGaD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.000144	0.0128	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.000137	0.0122	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.000134	0.0119	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.000118	0.0105	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Other—SMO—pancreatitis	0.000115	0.0102	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.000111	0.00988	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—NRAS—pancreatitis	0.000111	0.00983	CbGpPWpGaD
Cyclobenzaprine—Amitriptyline—ALB—pancreatitis	0.000109	0.0495	CrCbGaD
Cyclobenzaprine—CYP1A2—Tryptophan metabolism—ALDH2—pancreatitis	0.000107	0.00954	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.000103	0.00919	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	9.98e-05	0.00887	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Other—CNR1—pancreatitis	9.71e-05	0.00864	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—KRAS—pancreatitis	9.51e-05	0.00846	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—FDX1—pancreatitis	9.03e-05	0.00803	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—TACR1—pancreatitis	8.79e-05	0.00782	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—ADH4—pancreatitis	8.39e-05	0.00746	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	8.3e-05	0.00738	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Tryptophan metabolism—ALDH2—pancreatitis	8.28e-05	0.00736	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—CASR—pancreatitis	8.18e-05	0.00727	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HRAS—pancreatitis	8.09e-05	0.00719	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—CCK—pancreatitis	7.81e-05	0.00694	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL13—pancreatitis	7.79e-05	0.00693	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	7.7e-05	0.00685	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—FDX1—pancreatitis	7.65e-05	0.0068	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—TACR1—pancreatitis	7.61e-05	0.00676	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—CCKAR—pancreatitis	7.48e-05	0.00665	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CASR—pancreatitis	7.32e-05	0.00651	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—ADH4—pancreatitis	7.11e-05	0.00632	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	7.03e-05	0.00625	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatitis	7.01e-05	0.00623	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—pancreatitis	6.98e-05	0.00621	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—SST—pancreatitis	6.84e-05	0.00608	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—pancreatitis	6.8e-05	0.00605	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—pancreatitis	6.69e-05	0.00595	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—LPL—pancreatitis	6.38e-05	0.00567	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—ADH1B—pancreatitis	6.26e-05	0.00556	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—MTNR1B—pancreatitis	6.03e-05	0.00536	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	5.93e-05	0.00528	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—FDX1—pancreatitis	5.9e-05	0.00525	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—EGR1—pancreatitis	5.9e-05	0.00525	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—CNR2—pancreatitis	5.88e-05	0.00523	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatitis	5.78e-05	0.00514	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—BDKRB2—pancreatitis	5.56e-05	0.00494	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—ADH4—pancreatitis	5.49e-05	0.00488	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	5.43e-05	0.00483	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—PPY—pancreatitis	5.34e-05	0.00475	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CX3CL1—pancreatitis	5.31e-05	0.00472	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—ADH1B—pancreatitis	5.3e-05	0.00471	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—GCG—pancreatitis	5.27e-05	0.00469	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—pancreatitis	5.17e-05	0.0046	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatitis	5.17e-05	0.0046	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—KNG1—pancreatitis	5.06e-05	0.0045	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatitis	5.04e-05	0.00448	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TACR1—pancreatitis	5.04e-05	0.00448	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—pancreatitis	4.97e-05	0.00442	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatitis	4.96e-05	0.00441	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL10—pancreatitis	4.87e-05	0.00433	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—pancreatitis	4.72e-05	0.00419	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	4.58e-05	0.00407	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—pancreatitis	4.53e-05	0.00402	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—ALDH2—pancreatitis	4.41e-05	0.00392	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—BDKRB2—pancreatitis	4.3e-05	0.00382	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—CNR1—pancreatitis	4.22e-05	0.00375	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—SCT—pancreatitis	4.13e-05	0.00367	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CASR—pancreatitis	4.13e-05	0.00367	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—ADH1B—pancreatitis	4.09e-05	0.00364	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CX3CL1—pancreatitis	4.05e-05	0.0036	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—MTNR1B—pancreatitis	3.94e-05	0.0035	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CCK—pancreatitis	3.94e-05	0.0035	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—SST—pancreatitis	3.92e-05	0.00348	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—TACR1—pancreatitis	3.84e-05	0.00341	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CNR2—pancreatitis	3.84e-05	0.00341	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Tryptophan metabolism—MDM2—pancreatitis	3.8e-05	0.00338	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CCKAR—pancreatitis	3.77e-05	0.00336	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—ALDH2—pancreatitis	3.74e-05	0.00332	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—BDKRB2—pancreatitis	3.68e-05	0.00327	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatitis	3.66e-05	0.00326	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatitis	3.62e-05	0.00321	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatitis	3.43e-05	0.00305	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—pancreatitis	3.41e-05	0.00303	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—KNG1—pancreatitis	3.35e-05	0.00298	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—PTHLH—pancreatitis	3.26e-05	0.0029	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—SMO—pancreatitis	3.26e-05	0.0029	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PPY—pancreatitis	3.02e-05	0.00268	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—SST—pancreatitis	2.98e-05	0.00265	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—FDX1—pancreatitis	2.94e-05	0.00261	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Tryptophan metabolism—MDM2—pancreatitis	2.93e-05	0.00261	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—ALDH2—pancreatitis	2.88e-05	0.00256	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatitis	2.85e-05	0.00254	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—BDKRB2—pancreatitis	2.8e-05	0.00249	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—pancreatitis	2.8e-05	0.00249	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CNR1—pancreatitis	2.75e-05	0.00245	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PPY—pancreatitis	2.74e-05	0.00244	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—CXCL8—pancreatitis	2.66e-05	0.00237	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—GCG—pancreatitis	2.66e-05	0.00236	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatitis	2.65e-05	0.00236	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL1B—pancreatitis	2.56e-05	0.00227	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—KNG1—pancreatitis	2.55e-05	0.00227	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—CASP3—pancreatitis	2.55e-05	0.00227	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatitis	2.47e-05	0.0022	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatitis	2.47e-05	0.0022	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatitis	2.45e-05	0.00218	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PNLIP—pancreatitis	2.43e-05	0.00216	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—SCT—pancreatitis	2.33e-05	0.00207	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CASR—pancreatitis	2.33e-05	0.00207	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CCK—pancreatitis	2.22e-05	0.00198	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—MTNR1B—pancreatitis	2.22e-05	0.00198	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CNR2—pancreatitis	2.17e-05	0.00193	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—TACR1—pancreatitis	2.17e-05	0.00193	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CCL5—pancreatitis	2.13e-05	0.0019	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CCKAR—pancreatitis	2.13e-05	0.0019	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—SCT—pancreatitis	2.12e-05	0.00188	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CASR—pancreatitis	2.12e-05	0.00188	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatitis	2.09e-05	0.00185	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CX3CL1—pancreatitis	2.08e-05	0.00185	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—MTNR1B—pancreatitis	2.02e-05	0.0018	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CCK—pancreatitis	2.02e-05	0.0018	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CNR2—pancreatitis	1.97e-05	0.00175	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—TACR1—pancreatitis	1.97e-05	0.00175	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CCKAR—pancreatitis	1.94e-05	0.00172	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	1.93e-05	0.00172	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—TNF—pancreatitis	1.85e-05	0.00165	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PTHLH—pancreatitis	1.84e-05	0.00164	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PNLIP—pancreatitis	1.8e-05	0.0016	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CTRB2—pancreatitis	1.78e-05	0.00158	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—SST—pancreatitis	1.69e-05	0.0015	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PTHLH—pancreatitis	1.67e-05	0.00149	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—SMO—pancreatitis	1.67e-05	0.00149	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatitis	1.65e-05	0.00147	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	1.62e-05	0.00144	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PPY—pancreatitis	1.62e-05	0.00144	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PPP3CA—pancreatitis	1.6e-05	0.00142	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—BDKRB2—pancreatitis	1.59e-05	0.00141	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—A2M—pancreatitis	1.57e-05	0.00139	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CNR1—pancreatitis	1.56e-05	0.00138	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—FDX1—pancreatitis	1.54e-05	0.00137	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—SST—pancreatitis	1.53e-05	0.00136	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	1.53e-05	0.00136	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CTRB2—pancreatitis	1.51e-05	0.00134	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—GCG—pancreatitis	1.5e-05	0.00134	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL6—pancreatitis	1.5e-05	0.00133	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CCL2—pancreatitis	1.47e-05	0.00131	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—KNG1—pancreatitis	1.44e-05	0.00128	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—BDKRB2—pancreatitis	1.44e-05	0.00128	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ADH4—pancreatitis	1.44e-05	0.00128	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatitis	1.42e-05	0.00127	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CNR1—pancreatitis	1.41e-05	0.00126	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—GCG—pancreatitis	1.36e-05	0.00121	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PRSS1—pancreatitis	1.35e-05	0.0012	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—KNG1—pancreatitis	1.31e-05	0.00116	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—FDX1—pancreatitis	1.31e-05	0.00116	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PRSS3—pancreatitis	1.28e-05	0.00114	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PNLIP—pancreatitis	1.28e-05	0.00114	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FGG—pancreatitis	1.25e-05	0.00111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SCT—pancreatitis	1.25e-05	0.00111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CASR—pancreatitis	1.25e-05	0.00111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CX3CL1—pancreatitis	1.23e-05	0.00109	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ADH4—pancreatitis	1.22e-05	0.00108	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatitis	1.21e-05	0.00108	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CCL5—pancreatitis	1.21e-05	0.00107	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCK—pancreatitis	1.19e-05	0.00106	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MTNR1B—pancreatitis	1.19e-05	0.00106	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CTRB2—pancreatitis	1.16e-05	0.00104	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CNR2—pancreatitis	1.16e-05	0.00103	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—A2M—pancreatitis	1.16e-05	0.00103	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TACR1—pancreatitis	1.16e-05	0.00103	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CXCL8—pancreatitis	1.16e-05	0.00103	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—pancreatitis	1.16e-05	0.00103	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—XDH—pancreatitis	1.15e-05	0.00102	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCKAR—pancreatitis	1.14e-05	0.00102	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PRSS1—pancreatitis	1.14e-05	0.00102	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CCL5—pancreatitis	1.1e-05	0.000974	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PNLIP—pancreatitis	1.08e-05	0.000964	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PRSS3—pancreatitis	1.08e-05	0.000964	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ADH1B—pancreatitis	1.07e-05	0.000952	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FGA—pancreatitis	1.06e-05	0.000946	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—FDX1—pancreatitis	1.01e-05	0.000898	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SMO—pancreatitis	9.89e-06	0.000879	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PTHLH—pancreatitis	9.89e-06	0.000879	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—XDH—pancreatitis	9.72e-06	0.000864	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FGB—pancreatitis	9.68e-06	0.00086	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PPP3CA—pancreatitis	9.43e-06	0.000839	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ADH4—pancreatitis	9.39e-06	0.000834	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ADH1B—pancreatitis	9.07e-06	0.000806	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SST—pancreatitis	9.04e-06	0.000804	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—DUSP6—pancreatitis	8.96e-06	0.000797	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PRSS1—pancreatitis	8.82e-06	0.000785	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PLA2G1B—pancreatitis	8.54e-06	0.000759	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—pancreatitis	8.53e-06	0.000758	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—BDKRB2—pancreatitis	8.5e-06	0.000756	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PRSS3—pancreatitis	8.37e-06	0.000744	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PNLIP—pancreatitis	8.37e-06	0.000744	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CNR1—pancreatitis	8.35e-06	0.000742	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—A2M—pancreatitis	8.25e-06	0.000733	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GCG—pancreatitis	8.06e-06	0.000717	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KNG1—pancreatitis	7.74e-06	0.000688	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CCL2—pancreatitis	7.54e-06	0.000671	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALDH2—pancreatitis	7.54e-06	0.00067	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—XDH—pancreatitis	7.5e-06	0.000667	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PLA2G1B—pancreatitis	7.23e-06	0.000643	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PDGFA—pancreatitis	7.11e-06	0.000633	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ADH1B—pancreatitis	7e-06	0.000622	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—A2M—pancreatitis	6.98e-06	0.000621	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CXCL8—pancreatitis	6.57e-06	0.000584	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCL5—pancreatitis	6.47e-06	0.000575	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALDH2—pancreatitis	6.39e-06	0.000568	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LPL—pancreatitis	6.33e-06	0.000562	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	6.23e-06	0.000554	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SPP1—pancreatitis	5.99e-06	0.000533	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CXCL8—pancreatitis	5.96e-06	0.00053	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GCG—pancreatitis	5.72e-06	0.000508	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	5.6e-06	0.000498	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PLA2G1B—pancreatitis	5.58e-06	0.000496	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—A2M—pancreatitis	5.39e-06	0.000479	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LEP—pancreatitis	5.3e-06	0.000471	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALDH2—pancreatitis	4.93e-06	0.000438	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	4.9e-06	0.000436	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GCG—pancreatitis	4.84e-06	0.00043	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—NRAS—pancreatitis	4.79e-06	0.000425	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—INS—pancreatitis	4.53e-06	0.000403	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LPL—pancreatitis	4.48e-06	0.000399	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCL2—pancreatitis	4.46e-06	0.000396	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—KRAS—pancreatitis	4.12e-06	0.000366	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LPL—pancreatitis	3.8e-06	0.000338	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MDM2—pancreatitis	3.77e-06	0.000335	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GCG—pancreatitis	3.74e-06	0.000332	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CXCL8—pancreatitis	3.52e-06	0.000313	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HRAS—pancreatitis	3.5e-06	0.000311	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CASP3—pancreatitis	3.37e-06	0.0003	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL6—pancreatitis	3.35e-06	0.000298	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPARG—pancreatitis	3.27e-06	0.000291	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—INS—pancreatitis	3.21e-06	0.000286	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALB—pancreatitis	2.94e-06	0.000262	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LPL—pancreatitis	2.93e-06	0.000261	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NRAS—pancreatitis	2.83e-06	0.000251	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPARG—pancreatitis	2.77e-06	0.000247	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—INS—pancreatitis	2.72e-06	0.000242	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TGFB1—pancreatitis	2.63e-06	0.000234	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PTGS2—pancreatitis	2.58e-06	0.000229	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALB—pancreatitis	2.49e-06	0.000222	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KRAS—pancreatitis	2.43e-06	0.000216	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PTGS2—pancreatitis	2.18e-06	0.000194	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPARG—pancreatitis	2.14e-06	0.00019	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—INS—pancreatitis	2.1e-06	0.000187	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HRAS—pancreatitis	2.07e-06	0.000184	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL6—pancreatitis	1.98e-06	0.000176	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALB—pancreatitis	1.92e-06	0.000171	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PTGS2—pancreatitis	1.68e-06	0.00015	CbGpPWpGaD
